{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:02:22Z","timestamp":1782990142370,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81360220"],"award-info":[{"award-number":["81360220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale and objectives<\/jats:title>\n                    <jats:p>Early recurrence after curative resection remains a major determinant of poor prognosis in intrahepatic cholangiocarcinoma (ICC). Existing multimodal prediction models often lack interpretability due to feature interference during fusion. This study aimed to develop and externally validate an interpretable multimodal machine-learning model using a novel Independent Feature Selection and Consistent Integration (IFSCI) framework, combined with SHAP-based explanation to enhance transparency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A total of 264 patients with mass-forming ICC who underwent radical resection were retrospectively enrolled from two centers. Clinical and CT-based radiomics features were independently selected within each modality using statistical testing and LASSO under the IFSCI design, ensuring modality-specific interpretability before consistent integration. Support vector machine (SVM), random forest (RF), and multilayer perceptron (MLP) algorithms were used to construct clinical, radiomics, and combined models. Model performance was evaluated using AUC, calibration curves, Brier score, and decision curve analysis (DCA). SHAP values were applied to provide global and case-level interpretability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six clinical and twenty radiomics features were retained. The MLP-based combined model demonstrated the best performance, with AUCs of 0.933 (training), 0.891 (internal validation), and 0.856 (external validation). Calibration and Brier scores confirmed good agreement, and DCA indicated clinical benefit across 10\u201330% threshold probabilities. SHAP visualizations revealed feature importance hierarchies and clarified the decision logic for individual predictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>By integrating IFSCI with SHAP-based explanations, this study provides a transparent, high-performance multimodal framework for early recurrence prediction in ICC, facilitating clinically trustworthy and interpretable decision support.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40644-025-00987-6","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:44:24Z","timestamp":1767926664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel interpretable machine learning framework integrating clinicopathological and radiomic features for early recurrence prediction in mass-forming intrahepatic cholangiocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiao-li","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-hui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-yuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"987_CR1","doi-asserted-by":"crossref","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu. AX. Biliary tract cancer. Lancet. 2021;397:428\u201344.","DOI":"10.1016\/S0140-6736(21)00153-7"},{"key":"987_CR2","doi-asserted-by":"crossref","unstructured":"Bekki Y, von Ahrens D, Takahashi H, Schwartz M, Gunasekaran G. Recurrent intrahepatic cholangiocarcinoma: review. Front Oncol. 2021;11.","DOI":"10.3389\/fonc.2021.776863"},{"key":"987_CR3","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel R L, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","DOI":"10.3322\/caac.21834"},{"key":"987_CR4","doi-asserted-by":"crossref","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, Paulson AS, Borad MJ, Gallinson D, Murphy AG, Oh DY, Dotan E, Catenacci DV, Van Cutsem E, Ji T, Lihou CF, Zhen H. F\u00e9liz L and Vogel A. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21:671\u201384.","DOI":"10.1016\/S1470-2045(20)30109-1"},{"key":"987_CR5","doi-asserted-by":"crossref","unstructured":"Zerunian M, Polidori T, Palmeri F, Nardacci S, Del Gaudio A, Masci B, Tremamunno G, Polici M, De Santis D, Pucciarelli F, Laghi A, Caruso D. Artificial intelligence and radiomics in cholangiocarcinoma: a comprehensive review. Diagnostics. 2025;15:148.","DOI":"10.3390\/diagnostics15020148"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. J Hepatol. 2020;72:95\u2013103.","journal-title":"J Hepatol"},{"key":"987_CR7","doi-asserted-by":"crossref","unstructured":"Doussot A, Gonen M, Wiggers JK, Groot-Koerkamp B, DeMatteo RP, Fuks D, Allen PJ, Farges O, Kingham TP, Regimbeau JM, D\u2019Angelica MI, Azoulay D, Jarnagin WR. Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg. 2016;223:493\u2013505.e2.","DOI":"10.1016\/j.jamcollsurg.2016.05.019"},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/bjs.10676","volume":"105","author":"X-F Zhang","year":"2018","unstructured":"Zhang X-F, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Pawlik TM. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018;105:848\u201356.","journal-title":"Br J Surg"},{"key":"987_CR9","doi-asserted-by":"crossref","unstructured":"Li Q, Zhang J, Chen C, Song T, Qiu Y, Mao X, Wu H, He Y, Cheng Z, Zhai W, Li J, Zhang D, Geng Z, Tang Z. A nomogram model to predict early recurrence of patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy guidance: a multi-institutional analysis. Front Oncol. 2022;12:896764.","DOI":"10.3389\/fonc.2022.896764"},{"key":"987_CR10","doi-asserted-by":"crossref","unstructured":"Yoh T, Hatano E, Seo S, Okuda Y, Fuji H, Ikeno Y, Taura K, Yasuchika K, Okajima H, Kaido T, Uemoto S. Long-term survival of recurrent intrahepatic cholangiocarcinoma: the impact and selection of repeat surgery. World J Surg. 2018;42:1848\u201356.","DOI":"10.1007\/s00268-017-4387-7"},{"key":"987_CR11","doi-asserted-by":"crossref","unstructured":"Kojima T, Umeda Y, Fuji T, Niguma T, Sato D, Endo Y, Sui K, Inagaki M, Oishi M, Ota T, Hioki K, Matsuda T, Aoki H, Hirai R, Kimura M, Yagi T, Fujiwara T. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: a multi-institutional study by the Okayama Study Group of HBP surgery. PLoS One. 2020;15:e0238392.","DOI":"10.1371\/journal.pone.0238392"},{"key":"987_CR12","doi-asserted-by":"crossref","unstructured":"Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500\u201310.","DOI":"10.1038\/s41568-018-0016-5"},{"key":"987_CR13","doi-asserted-by":"crossref","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RGPM, Granton P, Zegers CML, Gillies R, Boellard R. Dekker A, Aerts HJWL. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441\u20136.","DOI":"10.1016\/j.ejca.2011.11.036"},{"key":"987_CR14","doi-asserted-by":"crossref","unstructured":"Chen P, Yang Z, Zhang H, Huang G, Li Q, Ning P, Yu H. Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: application and development trend. Front Oncol. 2023;13.","DOI":"10.3389\/fonc.2023.1133867"},{"key":"987_CR15","doi-asserted-by":"crossref","unstructured":"Deng L, Chen B, Zhan C, Yu H, Zheng J, Bao W, Deng T, Zheng C, Wu L, Yang Y, Yu Z, Wang Y, Chen G. A novel clinical-radiomics model based on sarcopenia and radiomics for predicting the prognosis of intrahepatic cholangiocarcinoma after radical hepatectomy. Front Oncol. 2021;11.","DOI":"10.3389\/fonc.2021.744311"},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"107612","DOI":"10.1016\/j.compbiomed.2023.107612","volume":"167","author":"B Chen","year":"2023","unstructured":"Chen B, Mao Y, Li J, Zhao Z, Chen Q, Yu Y, Yang Y, Dong Y, Lin G, Yao J, Lu M, Wu L, Bo Z, Chen G, Xie X. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study. Comput Biol Med. 2023;167:107612.","journal-title":"Comput Biol Med"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1007\/s00330-021-07926-6","volume":"31","author":"HJ Park","year":"2021","unstructured":"Park HJ, Park B, Park SY, Choi SH, Rhee H, Park JH, Cho E-S, Yeom S-K, Park S, Park M-S, Lee SS. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features. Eur Radiol. 2021;31:8638\u201348.","journal-title":"Eur Radiol"},{"key":"987_CR18","doi-asserted-by":"crossref","unstructured":"Nikolaou N, Salazar D, RaviPrakash H, Gon\u00e7alves M, Mulla R, Burlutskiy N, Markuzon N, Jacob E. Quantifying the advantage of multimodal data fusion for survival prediction in cancer patients. 2024;2024.01.08.574756.","DOI":"10.1101\/2024.01.08.574756"},{"key":"987_CR19","doi-asserted-by":"crossref","unstructured":"Kline A, Wang H, Li Y, Dennis S, Hutch M, Xu Z, Wang F, Cheng F, Luo Y. Multimodal machine learning in precision health: a scoping review. NPJ Digit Med. 2022;5:1\u201314.","DOI":"10.1038\/s41746-022-00712-8"},{"key":"987_CR20","doi-asserted-by":"crossref","unstructured":"Kalantar R, Lin G, Winfield JM, Messiou C, Lalondrelle S, Blackledge MD, Koh D-M. Automatic segmentation of pelvic cancers using deep learning: state-of-the-art approaches and challenges. Diagnostics. 2021;11:1964.","DOI":"10.3390\/diagnostics11111964"},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13014-022-02148-6","volume":"17","author":"C Yang","year":"2022","unstructured":"Yang C, Qin L, Xie Y, Liao J. Deep learning in CT image segmentation of cervical cancer: a systematic review and meta-analysis. Radiat Oncol. 2022;17:175.","journal-title":"Radiat Oncol"},{"key":"987_CR22","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions Proceedings of the 31st International Conference on Neural Information Processing Systems NIPS\u201917. (Red Hook, NY, USA: Curran Associates Inc.); 2017. pp 4768\u201377."},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.eururo.2014.11.025","volume":"67","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Eur Urol. 2015;67:1142\u201351.","journal-title":"Eur Urol"},{"key":"987_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11547-023-01597-7","volume":"128","author":"X Qian","year":"2023","unstructured":"Qian X, Zhou C, Wang F, Lu X, Zhang Y, Chen L, Zeng M. Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics. Radiol Med. 2023;128:274\u201388.","journal-title":"Radiol Med"},{"key":"987_CR25","doi-asserted-by":"crossref","unstructured":"Qiang Z, Zhang W, Jin S, Dai K, He Y, Tao L, Yu H. Carcinoembryonic antigen, \u03b1-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: a retrospective cohort study. Ann Hepatol. 2021;20:100242.","DOI":"10.1016\/j.aohep.2020.07.010"},{"key":"987_CR26","doi-asserted-by":"crossref","unstructured":"Saqub H, Proetsch-Gugerbauer H, Bezrookove V, Nosrati M, Vaquero EM, de Semir D, Ice RJ, McAllister S, Soroceanu L, Kashani-Sabet M, Osorio R, Dar AA. Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2\/5\/9. Sci Rep. 2020;10:18489.","DOI":"10.1038\/s41598-020-75578-5"},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4143\/crt.2020.192","volume":"53","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang L, Lu S, Xiang Y, Zeng C, He T, Ding Y, Wang W. Long Non-coding RNA CASC15 promotes intrahepatic cholangiocarcinoma possibly through inducing PRDX2\/PI3K\/AKT axis. Cancer Res Treat. 2021;53:184\u201398.","journal-title":"Cancer Res Treat"},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1097\/MEG.0b013e328364130f","volume":"25","author":"X Yin","year":"2013","unstructured":"Yin X, Zheng S-S, Zhang B-H, Zhou Y, Chen X-H, Ren Z-G, Qiu S-J, Fan J. Elevation of serum \u03b3-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study. Eur J Gastroenterol Hepatol. 2013;25:1408\u201314.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"987_CR29","doi-asserted-by":"crossref","unstructured":"Li X, Sun Z, Li X, Wang Q, Chen M, Zhang B, Feng Y, Han B, Hu X, Guo J, Wang M, Ma K. Biomarkers for predicting the prognosis of intrahepatic cholangiocarcinoma: a retrospective single-center study. Med (Baltim). 2023;102e33314.","DOI":"10.1097\/MD.0000000000033314"},{"key":"987_CR30","doi-asserted-by":"crossref","unstructured":"Fan Y, Ren X, Liu X, Shi D, Xu E, Wang S, Liu Y. Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients. Sci Rep. 2021;11:6651.","DOI":"10.1038\/s41598-021-85029-4"},{"key":"987_CR31","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu H, Zhang J, Wu Y, Zhou W, Cheng Z, Lou J, Zheng S, Bi X, Wang J, Guo W, Li F, Wang J, Zheng Y, Li J, Cheng S, Zeng Y, Liu J. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China. BMC Cancer. 2021;21:1299.","DOI":"10.1186\/s12885-021-09035-5"},{"key":"987_CR32","doi-asserted-by":"crossref","unstructured":"Ohguchi S, Nakatsukasa H, Higashi T, Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu S, Tsuji T. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Hepatology. 1998;27:599\u2013607.","DOI":"10.1002\/hep.510270239"},{"key":"987_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1102\/1470-7330.2013.0015","volume":"13","author":"B Ganeshan","year":"2013","unstructured":"Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer Imaging. 2013;13:140\u20139.","journal-title":"Cancer Imaging"},{"key":"987_CR34","doi-asserted-by":"publisher","first-page":"12529","DOI":"10.1038\/s41598-019-48738-5","volume":"9","author":"TT Tang","year":"2019","unstructured":"Tang TT, Zawaski JA, Francis KN, Qutub AA, Gaber MW. Image-based classification of tumor type and growth rate using machine learning: a preclinical study. Sci Rep. 2019;9:12529.","journal-title":"Sci Rep"},{"key":"987_CR35","doi-asserted-by":"crossref","unstructured":"Limkin EJ, Reuz\u00e9 S, Carr\u00e9 A, Sun R, Schernberg A, Alexis A, Deutsch E. Fert\u00e9 C, Robert C. The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features. Sci Rep. 2019;9:4329.","DOI":"10.1038\/s41598-019-40437-5"},{"key":"987_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1109\/MSP.2017.2738401","volume":"34","author":"D Ramachandram","year":"2017","unstructured":"Ramachandram D, Taylor GW. Deep multimodal learning: A survey on recent advances and trends. IEEE Signal Process Mag. 2017;34:96\u2013108.","journal-title":"IEEE Signal Process Mag"},{"key":"987_CR37","doi-asserted-by":"crossref","unstructured":"Bayoudh K, Knani R, Hamdaoui F, Mtibaa A. A survey on deep multimodal learning for computer vision: advances, trends, applications, and datasets. Vis Comput. 2022;38:2939\u201370.","DOI":"10.1007\/s00371-021-02166-7"},{"key":"987_CR38","doi-asserted-by":"crossref","unstructured":"Patel R, Shah Y, Mankodia A, Shah VA, Thakker M. Comparison of supervised machine learning methods for prostate cancer predication. AIP Conf Proc. 2024;3107:050020.","DOI":"10.1063\/5.0211647"},{"key":"987_CR39","unstructured":"Tolstikhin I, Houlsby N, Kolesnikov A, Beyer L, Zhai X, Unterthiner T, Yung J, Steiner A, Keysers D, Uszkoreit J, Lucic M, Dosovitskiy A. MLP-Mixer: an all-MLP architecture for vision. 2021."}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00987-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:21:10Z","timestamp":1781626870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-025-00987-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00987-6","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Review Committee of the First Affiliated Hospital of Guangxi Medical University approved this retrospective study, granting a waiver for informed consent. (Approval Number: 2025-E0324)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}